ATS 2018 International Conference - Mobile

Influence of Key Clinical Baseline Factors on Benralizumab Efficacy for Patients with Severe, Uncontrolled Asthma [Board No. 424]

Location: Board no. 424

Session Type: RAPiD: Rapid Abstract Poster Discussion Session

Sunday

May

20

2:15 PM

4:15 PM

Speaker(s)/Author(s)

Andrew Menzies-Gow

FRCP, PhD
Royal Brompton Hospital

Ian Hirsch

PhD
AstraZeneca

James G. Zangrilli

MD
AstraZeneca

Mitchell Goldman

MD, PhD
AstraZeneca

Paul Newbold

PhD
MedImmune LLC

Michael E. Wechsler

MD, MMSc
National Jewish Health

Yanping Wu

PhD
AstraZeneca

J. Mark. Fitzgerald

MD
Vancouver General Hospital, UBC Institute for Heart and Lung Health

Eugene R. Bleecker

MD
University of Arizona School of Medicine

View Abstract

Influence of Key Clinical Baseline Factors on Benralizumab Efficacy for Patients with Severe, Uncontrolled Asthma

Parent Sessions

A101 - MECHANISMS AND CLINICAL FEATURES OF SEVERE ASTHMA...
05-20-2018 2:15 PM - 4:15 PM